Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.

MLA

Zi-Ming Du, et al. “Upregulation of MiR-155 in Nasopharyngeal Carcinoma Is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A.” PLoS ONE, vol. 6, no. 4, Apr. 2011, p. e19137. EBSCOhost, https://doi.org/10.1371/journal.pone.0019137.

APA

Zi-Ming Du, Li-Fu Hu, Hai-Yun Wang, Li-Xu Yan, Yi-Xin Zeng, Jian-Yong Shao, & Ingemar Ernberg. (2011). Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS ONE, 6(4), e19137. https://doi.org/10.1371/journal.pone.0019137

Chicago

Zi-Ming Du, Li-Fu Hu, Hai-Yun Wang, Li-Xu Yan, Yi-Xin Zeng, Jian-Yong Shao, and Ingemar Ernberg. 2011. “Upregulation of MiR-155 in Nasopharyngeal Carcinoma Is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A.” PLoS ONE 6 (4): e19137. doi:10.1371/journal.pone.0019137.